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Abstract
Objective—This article describes radiologic and pulmonary function findings among miners 
exposed to Libby amphibole. Computed tomography permits the detection of the characteristic 
thin, lamellar pleural thickening (LPT).
Methods—Individuals who worked at the mine for a minimum of 6 months had chest CT and 
pulmonary function tests.
Results—Pleural thickening was noted in 223 (87%) of the 256 miners, parenchymal 
abnormalities in 49 (19%). LPT, found in 151 (68%), was associated with low values of forced 
vital capacity and diffusion capacity and significantly lower values in all pulmonary function tests 
when associated with parenchymal abnormalities.
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Conclusions—Eighty-seven percent of miners exposed to Libby Amphibole had pleural 
abnormalities on CT. LPT alone, and more so with parenchymal abnormalities, resulted in 
decreased pulmonary function. The importance of this easily-missed LPT is demonstrated by its 
high frequency and significant functional effects.
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INTRODUCTION
High rates of chest radiologic abnormalities have been reported in the population in and 
around Libby, MT, due to exposure to amphibole asbestos that contaminated the Libby 
vermiculite mine outside the town1. Morbidity and mortality from Libby Amphibole (LA) 
asbestos-related disease has been reported1–7. Sullivan reported that standardized mortality 
ratios for lung cancer, cancer of the pleura and asbestosis were 1.7, 23.3 and 165.8, 
respectively, when compared to the US white male population of the same age category6. 
Similar amphiboles have been detected in surface deposits in Nevada and Arizona8. A recent 
publication provided evidence that the increased incidence of mesothelioma in women and 
young individuals in southern Nevada may be linked to such environmental amphibole 
exposure9. In the Libby vermiculite-exposed population, we observed a different type of 
pleural disease in addition to the well-described circumscribed or diffuse pleural thickening, 
which are typically found in asbestos-exposed individuals. We called this different type of 
pleural disease “lamellar pleural thickening” (LPT)7, 10.
We previously reported illustrative cases of patients who developed pulmonary disease after 
LA-exposure10. These patients presented rapidly progressing dyspnea, chest pain, worsening 
pleural radiological changes, a restrictive pattern in pulmonary function tests and rapid loss 
of pulmonary function. These findings are atypical when compared to classical asbestos-
related disease. In a group of 189 volunteers who resided in Libby as children and 
adolescents but left before adulthood, 96 (48%) had pleural thickening on CT imaging with 
almost half of these being LPT. The severity of this LPT correlated with a decrease in 
pulmonary function7. LPT as found in Libby may be seen elsewhere but missed due to its 
non-traditional radiological features. In this report, we describe the radiologic and 
pulmonary function findings in former Libby miners who have been evaluated on repeated 
visits at the Center for Asbestos Related Disease (CARD) in Libby, MT, and who constitute 
the most heavily exposed group of the Libby population.
METHODS
During its 65 years of operation from the 1920s to 1990, 1862 individuals worked at the 
Libby vermiculite mine11. In July 2000, the CARD was established and has provided 
ongoing follow-up and imaging for the Libby exposed community. The CARD roster 
consists of approximately 5500 people; about 2000 of whom have been diagnosed with 
asbestos related disease (Black B, personal communication). This population includes 
former workers at the mine who have been evaluated on repeated clinical visits with 
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extensive information on their LA exposure, medical history, full pulmonary function tests 
(PFTs), and CT imaging.
Inclusion criteria
This report focuses on the 256 subjects who met the following entry criteria: a self-reported 
minimum six month history of working directly or as a contractor for the mine company, and 
had CT imaging at the time of inclusion. A total of 477 CARD patients initially identified 
themselves as miners. Seventy-two were removed as their work experience was less than six 
months, and an additional 18 were removed as they worked as contractors after the mine 
closed. Eighty-four of the remaining miners did not consent to participate, and 47 did not 
have CT imaging available at the time of inclusion. Figure 1 depicts the cohort. The research 
was performed under approval of the Institutional Review Board Spokane, WA.
All 256 subjects had completed standardized exposure questionnaires, including 
occupational, residential12 and smoking histories, and physical examination prior to 
inclusion. Exposure histories were analyzed as described previously12, and PFTs were 
performed at the CARD using American Thoracic Society criteria13. Static lung volumes 
were measured via plethysmography. Reference values for spirometry were from 
Hankinson14, lung volumes were from Crapo15 and DLco were from Miller16. Lower Limits 
of Normal (LLN), or upper limits of normal for residual volume, were used as criteria of 
abnormality.
CT imaging
Beginning in 2001, CT imaging was added to the radiologic testing performed at the CARD 
and it has provided a significant improvement in the detection of the pleural thickening 
frequently observed in the population7, 10, 17. Standard-dose chest CT scans were performed 
at the local hospital utilizing a 16 slice CT GE LightSpeed scanner (at 120 kVp and no more 
than 441 mAs) with 1-mm collimation. All identifiers were removed from the CT scan files, 
and readers were blind as to history and exposure status.
The most recent CT scan prior to date of inclusion was interpreted by consensus by 
academic thoracic radiologists with experience evaluating Libby disease (ML, YL, CH, DY), 
using lung (−500 level, 1400 width), mediastinal (40 level, 400 width), and extended-
mediastinal windows (−200 level, 3500 width, with adjustments)7. Radiologists performed 
standard clinical interpretation and the International Classification of Occupational and 
Environmental Respiratory Disease scoring system (ICO-ERD)18 as a CT-equivalent of the 
International Labour Organization Classification of x-rays for Pneumoconiosis19. In 
addition, radiologists were asked to differentiate between LPT7, 10 and circumscribed pleural 
thickening (CPT). When both were identified on CT scans, radiologists further determined if 
the pleural thickening was predominantly CPT or predominantly LPT.
CPT is defined as areas of pleural thickening with well-demarcated edges20. Diffuse pleural 
thickening on CT scan has been defined as a continuous sheet of pleural thickening more 
than 5 cm wide, more than 8 cm in cranio-caudal extent and more than 3 mm thick21. The 
2000 International Labour Organization Classification of Radiographs of Pneumoconiosis 
defines diffuse pleural thickening as that “extending up the lateral chest wall … only in the 
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presence of, and in continuity with, an obliterated costophrenic angle”19. These types of 
pleural thickening are different from what we have termed as LPT (Figure 2). We describe 
LPT as a thin layer of pleural thickening seen on CT scans internal and parallel to the ribs, 
but distinguished from subpleural fat7, 10, 22. It progressively extends vertically and along the 
inner border of the chest wall7, 10. It may progress in thickness and may calcify, becoming 
easier to identify and confirming its earlier recognition10.
Statistical Analysis
We calculated summary statistics of demographics, exposure estimates, and CT and PFT 
findings. Comparison between independent variables and categories of CT findings (i.e., CT 
groups) were evaluated by chi-square and analysis of variance. PFT percent predicted 
values, or ratio for FEV1/FVC, were compared between CT groups in general linear models, 
adjusting for covariates. Associations between abnormal PFT findings (i.e., below LLN) and 
CT findings were evaluated with unconditional logistic regression models. Initially, we 
modeled associations separately for each CT finding adjusted for covariates of latency and 
history of smoking. To account for multiple CT findings within miners we further included 
all CT findings in the model. All data analyses were conducted using SAS v9.3 (Cary, NC).
RESULTS
Table 1 provides the descriptive data for the 256 miners: 243 (95%) were male and almost 
half were 65 years or older (115, 45%). Twenty seven percent lived in Lincoln County for 25 
years or more prior to the closing of the mine, and the mean (standard deviation (SD)) 
occupational latency (i.e., years elapsed between first year of mine work and year of the CT 
used for the study) was 39 (8.2) years. Mean (SD) body mass index (BMI) was 31 (6.9) 
kg/m2, and over half (52.5%) of the participants were obese (i.e., BMI ≥ 30). Among the 256 
miners, 89 (34.8%) were never smokers, 43 (16.8%) were current smokers, 123 (48.1%) 
were former smokers, and 1 refused to provide the information. Sufficient information to 
calculate the pack-years of smoking was available on 146 (88%) of the 166 smokers and the 
mean (SD) was 30 (26). Mean (SD) quit time for the 123 former smokers was 26 years (14).
Table 2 shows the results of the CT interpretation for the 256 miners. No abnormalities 
could be identified on the CT scan in 30 (11.7%) of the miners, while 226 (88.3%) had some 
abnormality. Pleural thickening was the most frequent abnormality, noted in a total of 223 
(87.1%). Among these 223 miners, 151 (67.7%) had only or predominantly LPT, and 72 
(32.3%) had only or predominantly CPT. The 49 miners (19%) in whom parenchymal 
abnormalities were identified are reported in Table 2 using the ICO-ERD classification. 
These parenchymal abnormalities identified correspond to those seen in asbestosis (irregular 
opacities). Forty-seven of these had concomitant pleural thickening: 37 had LPT and the 
remaining 10 had CPT. Using clinical interpretation of the chest CT scan, two-thirds (33) of 
these 49 miners were also read as positive for “interstitial lung disease”. Emphysema with 
no other parenchymal abnormalities was found in 57 (22.3%) miners, all but one had pleural 
thickening (56/57). Fifteen of the 256 miners (5.9%) had emphysema, pleural thickening and 
irregular opacities.
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For subsequent comparisons with PFT findings, we grouped participants into eight mutually 
exclusive CT categories given in Table 3: CT negative (n = 30), CPT only (n = 35), LPT 
only (n = 52), both types but predominantly CPT (n = 11), both types but predominantly 
LPT (n = 37), CPT plus irregular opacities (n = 5), LPT plus irregular opacities (n = 27) and 
emphysema (n = 57). The two miners who had irregular opacities but no pleural thickening 
or emphysema were not included in these further analyses.
The participants’ characteristics with respect to the above described eight mutually exclusive 
CT categories are given in Table 3. Miners with any type of pleural thickening were of 
similar age as those with no abnormalities on CT scan, while those miners who had 
parenchymal abnormalities were significantly older. The few females in the study were more 
likely to be in the CT-negative group. Mean BMI was similar across eight groups, except it 
was significantly lower for those with emphysema (p < 0.05). Smoking history was similar 
among the eight groups, except for the emphysema group which was significantly higher 
(P< 0.01). Years of working at the mine company, years of residence and total environmental 
exposure were not significantly different between the CT positive and the CT negative 
groups, except those with emphysema who had longer residency time in the Libby area.
PFT data were available for 241 (94%) of miners. To best describe pulmonary function 
relevant to imaging studies, we limited our analysis to those miners whose PFTs were done 
within one year of the date of CT. Fourteen records were removed by this exclusion, 
resulting in 227 records with FEV1 and FVC data. Miners who were excluded from further 
PFT analysis (n=14) were not different from those included (n=227) with respect to percent 
male (93% versus 95%, respectively), percent overweight or obese (91% versus 88%, 
respectively) or percent current or former smokers (64% versus 65%, respectively). Fewer 
measures were available for DLco (n=158) and lung volumes (n=135). Mean PFT values by 
CT group are shown in Table 4 and all comparisons were adjusted for latency-years and 
smoking history. Those with both pleural thickening types were classified according to the 
predominant finding as identified by the radiologists, i.e., CPT or LPT. All the PFTs in the 
group with both LPT and parenchymal abnormalities were significantly lower than the CT 
negative group (p<0.05). DLco was lowest in the group with LPT and parenchymal 
abnormalities (p<0.002 compared to CT negative) and was lower in those with LPT than in 
those with CPT (p=0.016). The 57 miners with emphysema had lower values for FEV1, 
FEV1/FVC ratio and DLco compared to the CT negative (Table 4).
Table 5 shows the association between frequency of abnormal PFTs and CT findings. A 
substantial proportion of miners had FEV1 (35%), FVC (32%) and DLco (25%) below LLN. 
Adjusting only for latency and smoking history, we showed significantly elevated risk 
estimates for abnormal FEV1 and FVC among those with LPT compared to no pleural 
findings. Risk estimates for these parameters among those with CPT were not different from 
those with no pleural thickening. When further adjusting for other CT findings, the odds 
ratio for abnormal FVC remained independently elevated among those with LPT compared 
to no pleural thickening (OR (95% CI) = 3.9 (1.1 – 14)). Presence of irregular opacities and 
presence of emphysema were consistently associated with frequency of abnormal PFTs. 
Additional modeling using years of work as a proxy for exposure did not appreciably change 
(< 5%) the risk estimates (data not shown). Because we had insufficient data to calculate 
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pack-years for a substantial portion of the observations (i.e., approximately 12% of the 
smokers with PFT data), we used a categorical variable for smoking history in our primary 
analysis. In sensitivity analyses, we used pack-years in place of the categorical variable; the 
effect estimates for CT findings and PFT abnormality were similar, but that had larger 95% 
confidence intervals. For example, OR (95% CI) for CPT and abnormal FVC was 3.6 (1.0 – 
13).
LPT which cannot be identified on chest radiographs and is even difficult to recognize on 
CT scans until it has advanced or calcified, does lead to a decreased FEV1, FVC, TLC and 
DLco as shown in Tables 4 and 5.
DISCUSSION
This report focuses on a population of individuals who were heavily exposed to LA as a 
result of their occupation at the mine. Prior reports using chest radiographs rather than CT 
scans have demonstrated that Libby miners had pleural thickening, parenchymal 
abnormalities and restrictive findings on spirometry23.
Our investigation expands on previous studies by using the more sensitive and more accurate 
imaging modality of CT and the full spectrum of PFTs to evaluate the effect of pleural 
thickening and parenchymal abnormalities on pulmonary function findings. We found that 
223 (87%) of the 256 miners had pleural thickening and among them, 47 (21%) had 
associated parenchymal abnormalities. Among the 223 with pleural thickening, 68% had 
LPT rather than the classical CPT. We have previously introduced the concept of LPT to 
describe a thin layer of pleural thickening internal and parallel to the ribs, distinguished from 
subpleural fat, seen on CT scans of LA exposed individuals7, 10. LPT is different from the 
traditional diffuse pleural thickening classified under the International Labour Organization 
(ILO) guidelines for reading x-rays of pneumoconiosis19 and there is no specific category to 
describe it. While LPT is parietal in location, it does not fit the definition CPT since it lacks 
well-demarcated edges.
LPT cannot be identified on chest radiographs and is even difficult to recognize on CT scans 
until the pleural thickening becomes advanced or calcified. It does, however, lead to a 
decreased FEV1, FVC, TLC and DLco as shown in Tables 4 and 5. Our study demonstrates 
that occupational exposure to LA leads to high frequencies of pleural thickening, of which 
the majority of cases are LPT. Lung function deficits are more frequently associated with 
LPT than with CPT, particularly in the presence of concurrent parenchymal abnormalities. 
The importance of pleural thickening from LA was demonstrated by our previous study of 
198 subjects who had less intense environmental exposure only during childhood and 
adolescence, 96 (48%) of whom had pleural thickening. Of those with any pleural 
thickening, LPT was found in 47 (49%)7.
Two recent papers have reported pulmonary function abnormalities associated with CT 
evaluation of LA exposure. Clark24 found that 90% of 166 Libby vermiculite miners whose 
medical records between January 2000 and August 2012 were reviewed, presented pleural 
plaques, the majority of which were described as “bilateral and calcified”. Sixteen percent of 
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these workers had associated pulmonary fibrosis. No differences in PFT results were noted 
between those with only pleural plaques and those with no abnormalities on CT. Miners with 
both interstitial and pleural abnormalities had a significantly decreased TLC as compared to 
those with negative CT scans. Age, smoking and BMI were found to contribute to abnormal 
pulmonary function. While Clark did not differentiate CPT from LPT, we found similar 
percentages of overall pleural thickening in our group of miners (90% in Clark’s study as 
compared to 87% in our study). Additionally, similar to Clark’s findings, miners with both 
pleural thickening and parenchymal abnormalities in our study had significantly decreased 
PFTs. Our study, however, showed that presence of LPT among miners was independently 
associated with abnormal FVC after adjusting for presence of parenchymal abnormalities, 
thus showing that LPT alone contributes to impairment of pulmonary function.
Lockey and co-workers described CT findings in 191 workers with low exposure to LA 
working for a vermiculite expansion plant25. These authors found CT abnormalities in 55% 
of the workers: 53% had pleural thickening and 13% had parenchymal abnormalities. 
Localized pleural thickening, the description of which was that of plaques, was far more 
common and resulted in decreased FVC and FEV1. Decreased FVC and FEV1 were more 
marked in those who had pleural thickening and other abnormalities. Diffuse pleural 
thickening was described in only 8%, always in combination with localized thickening or 
parenchymal abnormalities, resulting in greater reduction in FVC. Our study found a higher 
incidence of pleural thickening among the Libby miners, which would be expected given 
that these miners had higher exposures. Similar to Lockey’s findings, in our study, miners 
with CPT had decreased pulmonary function as compared to miners with no abnormalities in 
their chest CT. Again, no distinction was made between CPT and LPT by Lockey’s group, 
and it is likely that many cases of LPT were not recognized. In a correspondence concerning 
their paper, Lockey reported results of additional PFTs showing that percent predicted TLC 
was decreased 3.6% and DLco was decreased 4.1% in those with limited pleural thickening 
only and much further in those with both pleural thickening and other findings26.
Other studies using CT scans of asbestos-exposed workers have shown that CPT (plaques) is 
associated with decreased spirometry values27 and diffuse thickening is additionally 
associated with decreased DLco28. A study of a large number (1584) of heavily exposed 
workers (long term insulators) using chest radiographs demonstrated that severity of CPT 
correlated with decreasing FVC and that diffuse thickening was associated with greater 
decrease in FVC irrespective of severity29. This distinction between the effects of different 
types of pleural thickening on pulmonary function is very similar to the differences observed 
in this current study between CPT and LPT.
The importance of CT evidence of pulmonary fibrosis is demonstrated in our study by the 
far greater decrease in all measures of pulmonary function in those miners with associated 
CT-detected parenchymal abnormalities. That the difference is most clearly seen with DLco 
is consistent with the sensitivity of this measurement for parenchymal lung involvement. 
That DLco is lower in LPT than CPT alone suggests that LPT may be associated with 
parenchymal inflammation or fibrosis that is not apparent on standard CT-window settings. 
A study in insulators using incremental exercise testing demonstrated evidence of 
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parenchymal involvement in those with pleural thickening only and no parenchymal 
abnormalities on chest radiographs30.
Limitations of this study may include sample selection. The authors believe, however, that 
the sample is representative of the overall LA mining population, as it included all former 
miners and contractors who are patients of CARD, which is the local reference center for all 
individuals exposed to LA. In addition, CARD maintains a nation-wide screening program 
that targets those who now live elsewhere.
The asbestos-related benign and malignant consequences of LA are of national significance 
since vermiculite was shipped (in open rail cars) throughout North America for processing. 
The consequences of such exposure have been reported from processing sites25, 31–37. In 
addition to the Libby product, similar amphiboles have been found in surface sites in several 
states in sufficient air-concentrations to cause disease. The elevated rates of mesothelioma in 
women and in young persons in Southern Nevada are consistent with environmental 
exposure to asbestos9. Recognition of the unique radiologic presentation of LA pleural 
disease is therefore critically important to the diagnosis of individual patients and to the 
public health of communities.
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Abbreviation List
BMI Body mass index
CARD Center for Asbestos Related Disease
CT Computed Tomography
CPT Circumscribed Pleural Thickening
DLco Carbon monoxide diffusing capacity of the lung
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FEV1 Forced Expiratory Volume in 1st second
FVC Forced Vital Capacity
ICO-ERD International Classification of HRCT for Occupational and Environmental 
Respiratory Diseases
LA Libby Amphibole
LLN Lower Limits of Normal
LPT Lamellar Pleural Thickening
PFT Pulmonary Function Test
SD Standard Deviation
TLC Total Lung Capacity
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Figure 1. Libby Vermiculite Miners cohort
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Figure 2. Lamellar Pleural Thickening
Figure 2A illustrates side-by-side chest CT images in extended lung windows and 
mediastinal windows of a miner with lamellar PT who is included in the present series. Lung 
window shows the characteristic thin layer of pleural thickening extending internal and 
parallel to the ribs, that has been characterized by the authors as lamellar thickening 
(arrows). This thickening can best be seen on the lung windows due to technical factors that 
make it less visible on mediastinal windows (Figure 2B, arrows). Figures 2C1 and 2C2 show 
two surgical images of the parietal pleura of this same patient during a thoracotomy for a 
lung cancer (Figure 2D, arrow). A thin layer of parietal pleural thickening that corresponds 
to the chest CT scan image of lamellar PT is clearly visible (black arrows), the remainder of 
the pleura is opaque.
AO = aorta; CW = parietal chest wall; H = heart; LUL = left upper lobe; LLL = left lower 
lobe; LLA = left lower lobe artery; LLB = left lower lobe bronchus; LLV = left lower lobe 
vein; PT = pleural thickening.
(Surgical photos courtesy of Dr. Steven J. Nisco, MD, Thoracic Surgeon, Providence 
Spokane Heart Institute, Spokane, WA)
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Table 1
Demographic characteristics, smoking history and exposure history of miners
N (%)
Gender
Female 13 (5.1)
Male 243 (94.9)
Age group
30 – 54 years 37 (14.5)
55 – 64 years 104 (40.6)
65 + years 115 (44.9)
Body Mass Index Category (BMI data missing for 33)
Normal (< 25 kg/m2) 26 (11.7)
Overweight (25–29.9 kg/m2) 80 (35.9)
Obese (>= 30 kg/m2) 117 (52.5)
Smoking History
Never 89 (34.8)
Current 43 (16.8)
Former 123 (48.1)
Missing/Refused 1 (0.4)
Latency (years since first worked at or contracted for WR Grace)
21–33 65 (25.4)
34–38 65 (25.4)
39–43 60 (23.4)
44–69 66 (25.8)
Years lived in Lincoln County prior to 1990
< 7 years 61 (23.8)
7 – 16 years 66 (25.8)
17 – 24 years 60 (23.4)
25 + years 69 (27.0)
Years worked at WRG
0.6 to 1.5 years 87 (34.0)
1.6 to 5 years 84 (32.8)
5.1 to 40 years 85 (33.2)
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Table 2
CT findings (Mutually exclusive)
CT Findings Number Percent
Normal 30 11.7
Pleural Thickening with no other findings
  CPT only 35 13.7
  Both types, but predominantly CPT 11 4.3
  LPT only 52 20.3
  Both types but predominantly LPT 37 14.5
Pleural Thickening + irregular opacitiesa
  CPTb + irregular opacities 5 2.0
  LPTc + irregular opacities 27 10.6
Pleural Thickening + emphysema
  CPTb + emphysema 16 6.3
  LPTc + emphysema 25 9.8
Pleural Thickening + irregular opacities + emphysema
  CPTb + irregular opacities + emphysema 5 2.0
  LPTc + irregular opacities + emphysema 10 3.9
Irregular opacities only 2 0.8
Emphysema only 1 0.4
Total 256 100
a
Irregular opacities include intra (including subpleural curvilinear opacities, 3 cases), interlobular opacities (45 cases) and honeycombing (1 case). 
Location of these abnormalities was predominantly in the middle and lower lobes in all cases.
b
Includes those with CPT and those with both types, but predominantly CPT.
c
Includes those with LPT and those with both types, but predominantly LPT.
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